Warning issued to sites illegally selling Adderall

The United States Food & Drug Administration (FDA) has sent warning letters to 2 websites that illegally sell Schedule II stimulants marketed as Adderall.

The warning letters were sent to Kubapharm.com and Premiumlightssupplier.com, claiming that drugs sold on those websites are mislabeled and in violation of the Federal Food, Drug, and Cosmetic (FD&C) Act. The FDA also said the websites violated the Ryan Haight Online Pharmacy Act (RHA) because they had not registered their online pharmacies with the US Drug Enforcement Administration (DEA). Both websites were given 15 business days to respond to the agencies with the steps they plan to take to address these violations.1

Because Adderall has a high potential for dependence and abuse, selling it without a prescription and without the supervision of a licensed healthcare provider puts consumers at risk of abuse and dependence, as well as harm. other potential harmful effects associated with the quality of the drug. Likewise, if the drug is sold illegally, there is no guarantee that the drug is not inauthentic, contaminated, expired, or otherwise harmful.1

“This action underscores FDA’s commitment to using all available regulatory and compliance tools to prevent online companies from illegally selling potentially harmful pharmaceutical products to consumers,” said FDA Commissioner Robert M. Califf. , MD, in a press release. “The illegal sale of prescription drug stimulants online puts Americans at risk and contributes to potential abuse, misuse, and overdose. These particular types of online pharmacies also undermine our efforts to help consumers safely purchase legitimate prescription medications over the Internet. The FDA will continue its partnership with the DEA in an effort to safeguard public health and protect consumers who need access to these important drugs. »

This article was originally published by sister publication Psychiatric Times.

Reference

1. FDA and FEA warns online pharmacies illegally selling Adderall to consumers. Press release. United States Food and Drug Administration. April 12, 2022. Accessed April 13, 2022.

About Rhonda Lee

Check Also

Five Doctors Plead Guilty to Federal Drug Crimes at HOPE Clinic | USAO-SDWV

CHARLESTON, W.Va. — Five doctors have pleaded guilty in connection with prescribing practices at the …